These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 19545477)

  • 1. Cocaine-mediated synaptic potentiation is absent in VTA neurons from mGlu5-deficient mice.
    Bird MK; Reid CA; Chen F; Tan HO; Petrou S; Lawrence AJ
    Int J Neuropsychopharmacol; 2010 Mar; 13(2):133-41. PubMed ID: 19545477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute and chronic cocaine-induced potentiation of synaptic strength in the ventral tegmental area: electrophysiological and behavioral correlates in individual rats.
    Borgland SL; Malenka RC; Bonci A
    J Neurosci; 2004 Aug; 24(34):7482-90. PubMed ID: 15329395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modifications of the input currents on VTA dopamine neurons following acute versus chronic cocaine exposure.
    Michaeli A; Matzner H; Poltyrev T; Yaka R
    Neuropharmacology; 2012 Mar; 62(4):1834-40. PubMed ID: 22197515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NR2A/B-containing NMDA receptors mediate cocaine-induced synaptic plasticity in the VTA and cocaine psychomotor sensitization.
    Schumann J; Matzner H; Michaeli A; Yaka R
    Neurosci Lett; 2009 Sep; 461(2):159-62. PubMed ID: 19524640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Orexin A in the VTA is critical for the induction of synaptic plasticity and behavioral sensitization to cocaine.
    Borgland SL; Taha SA; Sarti F; Fields HL; Bonci A
    Neuron; 2006 Feb; 49(4):589-601. PubMed ID: 16476667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of D2 dopamine receptor function modulates cocaine-induced glutamatergic synaptic potentiation in the ventral tegmental area.
    Madhavan A; Argilli E; Bonci A; Whistler JL
    J Neurosci; 2013 Jul; 33(30):12329-36. PubMed ID: 23884939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GABA site agonist gaboxadol induces addiction-predicting persistent changes in ventral tegmental area dopamine neurons but is not rewarding in mice or baboons.
    Vashchinkina E; Panhelainen A; Vekovischeva OY; Aitta-aho T; Ebert B; Ator NA; Korpi ER
    J Neurosci; 2012 Apr; 32(15):5310-20. PubMed ID: 22496576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In utero exposure to cocaine delays postnatal synaptic maturation of glutamatergic transmission in the VTA.
    Bellone C; Mameli M; Lüscher C
    Nat Neurosci; 2011 Oct; 14(11):1439-46. PubMed ID: 21964489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased gabaergic input to ventral tegmental area dopaminergic neurons associated with decreased cocaine reinforcement in mu-opioid receptor knockout mice.
    Mathon DS; Lesscher HM; Gerrits MA; Kamal A; Pintar JE; Schuller AG; Spruijt BM; Burbach JP; Smidt MP; van Ree JM; Ramakers GM
    Neuroscience; 2005; 130(2):359-67. PubMed ID: 15664692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylphenidate and amphetamine modulate differently the NMDA and AMPA glutamatergic transmission of dopaminergic neurons in the ventral tegmental area.
    Prieto-Gómez B; Vázquez-Alvarez AM; Martínez-Peña JL; Reyes-Vázquez C; Yang PB; Dafny N
    Life Sci; 2005 Jun; 77(6):635-49. PubMed ID: 15921995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cocaine-induced potentiation of synaptic strength in dopamine neurons: behavioral correlates in GluRA(-/-) mice.
    Dong Y; Saal D; Thomas M; Faust R; Bonci A; Robinson T; Malenka RC
    Proc Natl Acad Sci U S A; 2004 Sep; 101(39):14282-7. PubMed ID: 15375209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cocaine-evoked synaptic plasticity: persistence in the VTA triggers adaptations in the NAc.
    Mameli M; Halbout B; Creton C; Engblom D; Parkitna JR; Spanagel R; Lüscher C
    Nat Neurosci; 2009 Aug; 12(8):1036-41. PubMed ID: 19597494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Previous exposure to VTA amphetamine enhances cocaine self-administration under a progressive ratio schedule in an NMDA, AMPA/kainate, and metabotropic glutamate receptor-dependent manner.
    Suto N; Tanabe LM; Austin JD; Creekmore E; Vezina P
    Neuropsychopharmacology; 2003 Apr; 28(4):629-39. PubMed ID: 12655307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cadherins mediate cocaine-induced synaptic plasticity and behavioral conditioning.
    Mills F; Globa AK; Liu S; Cowan CM; Mobasser M; Phillips AG; Borgland SL; Bamji SX
    Nat Neurosci; 2017 Apr; 20(4):540-549. PubMed ID: 28192395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exposure of nicotine to ventral tegmental area slices induces glutamatergic synaptic plasticity on dopamine neurons.
    Jin Y; Yang K; Wang H; Wu J
    Synapse; 2011 Apr; 65(4):332-8. PubMed ID: 20730803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repeated administration of AMPA or a metabotropic glutamate receptor agonist into the rat ventral tegmental area augments the subsequent behavioral hyperactivity induced by cocaine.
    Dunn JM; Inderwies BR; Licata SC; Pierce RC
    Psychopharmacology (Berl); 2005 Apr; 179(1):172-80. PubMed ID: 15580483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epac Signaling Is Required for Cocaine-Induced Change in AMPA Receptor Subunit Composition in the Ventral Tegmental Area.
    Liu X; Chen Y; Tong J; Reynolds AM; Proudfoot SC; Qi J; Penzes P; Lu Y; Liu QS
    J Neurosci; 2016 Apr; 36(17):4802-15. PubMed ID: 27122037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cocaine disinhibits dopamine neurons by potentiation of GABA transmission in the ventral tegmental area.
    Bocklisch C; Pascoli V; Wong JC; House DR; Yvon C; de Roo M; Tan KR; Lüscher C
    Science; 2013 Sep; 341(6153):1521-5. PubMed ID: 24072923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cocaine exposure enhances excitatory synaptic drive to cholinergic neurons in the laterodorsal tegmental nucleus.
    Kurosawa R; Taoka N; Shinohara F; Minami M; Kaneda K
    Eur J Neurosci; 2013 Oct; 38(7):3027-35. PubMed ID: 23822660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. mGlu
    Turner BD; Rook JM; Lindsley CW; Conn PJ; Grueter BA
    Neuropsychopharmacology; 2018 Sep; 43(10):2075-2082. PubMed ID: 29654259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.